- Dr. Reddy's Launches Vigabatrin in the US
- Sustainable manufacturing practices to combat growing AMR
- Check-Cap, GE Healthcare announce updates on C-Scan System
- NOAC treatment effective against liver disease-associated atrial fibrillation
- Singapore National Eye Centre opens new facility
- Xynomic Research Institute designs potent RET Kinase Inhibitors
- AstraZeneca announces positive results for heart drug candidate
- Microsoft welcomes new Chief Medical Officer Dr. David Rhew
- FDA approves new antibiotic to treat community-acquired bacterial pneumonia
- Boston Scientific Closes Acquisition of BTG plc.
- Moderna Receives FDA Fast Track Designation for Zika Vaccine
- CStone submits an abstract on CS1001-201 trial to 2019 ASH Annual Meeting
- Following FDA approval, Wakix will gain a small share in narcolepsy market
- IDF Congress to bring together global diabetes community
-
Singapore | 09 July 2019 | News
Asia HealthTech momentum continues unabated closing H1 2019 at $2.5B
Galen Growth Asia, the leading exclusive HealthTech research, analytics and advisory firm in Asia Pac (Asia) s...Read more
Singapore | 04 July 2019 | News
Latest technologies to transform healthcare
A new consortium led by the Institute for Health Innovation and Technology (iHealthtech) at NUS will tap on th...Read more
-
India | 20 August 2019 | News
Dr. Reddy's Launches Vigabatrin in the US
Dr. Reddy’s Laboratories Ltd. has announced the launch of Vigabatrin Powder for Oral Solution, USP in 50...Read more
-
China | 20 August 2019 | News
Xynomic Research Institute designs potent RET Kinase Inhibitors
Xynomic Pharmaceuticals Holdings, Inc., a clinical stage US-China oncology drug development company, has annou...Read more
-
Middle East countries | 16 July 2019 | News
Filterlex Medical raises $3M in Series A Financing
Filterlex Medical is a medical device start-up company based in Israel, developing an innovative embolic ...Read more
-
Thailand | 30 July 2019 | News
Thai startups to capture a major chunk of healthcare market
The medical device market in ASEAN is predicted to be worth US$8.5 billion by 2021, and Thai entrepreneurs wan...Read more
Stem cells gaining importance
Stem cell research stands as a high-priority field in the Asia-Pacific (APAC) and investment in these facilities are growing in order to increase competitiveness in the free market so that clinical applications can be continually discovered. Stringent regulations in Western Europe and the USA in stem cell therapy and regenerative medicine have driven the APAC to grow at the highest rate in this industry. Stem cell therapy is a hot topic in the field of medicine and is growing at a fast pace, BioSpectrum takes a look at how this exciting field is faring in the APAC region.
